ATE400262T1 - Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität - Google Patents

Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität

Info

Publication number
ATE400262T1
ATE400262T1 AT04806247T AT04806247T ATE400262T1 AT E400262 T1 ATE400262 T1 AT E400262T1 AT 04806247 T AT04806247 T AT 04806247T AT 04806247 T AT04806247 T AT 04806247T AT E400262 T1 ATE400262 T1 AT E400262T1
Authority
AT
Austria
Prior art keywords
acid
hypersensitivity
treatment
hyperreactivity
medication
Prior art date
Application number
AT04806247T
Other languages
English (en)
Inventor
Frederick W Cain
Wiro Stam
Ulrike Schmid
Geoff Collins
Original Assignee
Lipid Nutrition Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipid Nutrition Bv filed Critical Lipid Nutrition Bv
Application granted granted Critical
Publication of ATE400262T1 publication Critical patent/ATE400262T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT04806247T 2003-12-19 2004-12-17 Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität ATE400262T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03258087 2003-12-19

Publications (1)

Publication Number Publication Date
ATE400262T1 true ATE400262T1 (de) 2008-07-15

Family

ID=34684630

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04806247T ATE400262T1 (de) 2003-12-19 2004-12-17 Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität

Country Status (9)

Country Link
US (1) US20110229563A1 (de)
EP (1) EP1694320B1 (de)
JP (1) JP2007514727A (de)
CN (1) CN1893937B (de)
AT (1) ATE400262T1 (de)
DE (1) DE602004014974D1 (de)
ES (1) ES2311177T3 (de)
PL (1) PL1694320T3 (de)
WO (1) WO2005058302A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107412775B (zh) * 2010-11-22 2021-01-05 菲尼克斯生物技术公司 用夹竹桃属物种或黄花夹竹桃属物种的提取物治疗神经病症的方法
PT2956440T (pt) 2013-02-08 2018-05-08 Gen Mills Inc Produtos alimentares com baixo teor de sódio
KR101645963B1 (ko) * 2014-05-13 2016-08-08 주식회사한국야쿠르트 사과박(apple pomace)으로부터 우르솔릭산을 고효율로 추출하는 방법 및 그 방법에 의해 추출된 우르솔릭산을 유효성분으로 함유하는 식품조성물
CN104610417B (zh) * 2015-02-16 2016-05-11 白心亮 一种从山楂中提取熊果酸和齐墩果酸的方法
MX2020002884A (es) * 2017-09-14 2020-10-05 Phoenix Biotechnology Inc Método y composición neuroprotectora mejorada para tratar afecciones neurológicas.
DE102018217341A1 (de) 2018-10-10 2020-04-16 Katjes Fassin GmbH.+Co. Kommanditgesellschaft Mit apfelwachs beschichtetes bonbon
JP7276745B2 (ja) * 2019-06-14 2023-05-18 地方独立行政法人青森県産業技術センター リンゴ由来トリテルペノイド含有組成物製造方法、ウルソール酸製造方法、およびオレアノール酸製造方法
CN112704663B (zh) * 2020-12-18 2022-07-19 吉林农业科技学院 一种枇杷叶熊果酸乳膏的制备方法
CN114129572B (zh) * 2021-12-16 2023-04-07 南开大学 一种协同抑制汉防己甲素诱导的药源性肝损伤的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03287530A (ja) * 1990-03-31 1991-12-18 Snow Brand Milk Prod Co Ltd 免疫抑制剤
JPH1112178A (ja) * 1997-06-23 1999-01-19 Dainippon Pharmaceut Co Ltd オレアノール酸系抗掻痒剤
DE60114708T2 (de) * 2000-06-05 2006-07-20 Loders Croklaan B.V. Ursolsäure und Oleanolsäure enthaltende Mischungen
DE60204078T2 (de) * 2001-04-09 2006-01-26 Loders Croklaan B.V. Konzentrat von Triterpenen
JP5081354B2 (ja) * 2001-11-07 2012-11-28 株式会社ナリス化粧品 IgE産生抑制剤

Also Published As

Publication number Publication date
ES2311177T3 (es) 2009-02-01
US20110229563A1 (en) 2011-09-22
PL1694320T3 (pl) 2008-11-28
EP1694320A1 (de) 2006-08-30
EP1694320B1 (de) 2008-07-09
CN1893937A (zh) 2007-01-10
JP2007514727A (ja) 2007-06-07
DE602004014974D1 (de) 2008-08-21
CN1893937B (zh) 2011-01-12
WO2005058302A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
Shetty et al. Survival rates of porcelain laminate restoration based on different incisal preparation designs: An analysis
DE602005019319D1 (de) Zusammensetzungen mit ornithin und phenylacetat oder phenylbutyrat zur behandlung von hepatischer enzephalopathie
IS8395A (is) Fjölvasýklískar karboxýlsýrur og asýlsúlfónamíð sem hindrar á lifrabólgu C eftirmyndun
DE60233967D1 (de) Verbesserte essbare filmformulierungen mit maltodextrin
DE60118723D1 (de) Verwendung von azetogenischen hydrogenotrophischen stämmen zur vorbeugung und behandlung von verdauungskrankheiten
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
TN2009000481A1 (en) Novel peptide inhibitors of hepatitis c virus replication
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
PH12021551011A1 (en) Compositions and methods for treating transient biofilms
ATE400262T1 (de) Verwendung von zusammensetzungen mit oleansäure und ursolsäure zur herstellung eines medikaments zur behandlung von überempfindlichkeit und hyperreaktivität
DE60323765D1 (de) Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
ATE406884T1 (de) Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
ATE306263T1 (de) Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
NZ774378A (en) Silicic acids for use in the treatment of periodontitis
BR9810567A (pt) Composições antimicrobianas sinérgicas contendo uma dimetilamida de um ácido carboxìlico com uma mistura de 2-(tiocianometiltio) benzotiazol e um metileno-bis (tiocianato) e uso destes
PL375299A1 (en) 3-heterocyclyl substituted benzoic acid derivatives
DE602004005455D1 (de) Verfahren zur behandlung oder prävention von chronischen wunden und komplette nahrungszusammensetzung mit glycin und/oder leucin zur verwendung darin
KR101985745B1 (ko) 설탕과 기능성 발효액을 이용한 필오프형 마스크팩
ATE385252T1 (de) Verfahren zur herstellung von granulatförmigen zusammensetzungen
WO2006071564A3 (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
ATE547120T1 (de) VERFAHREN ZUM EINKAPSELN VON ORAL AUFGENOMMENEN MATERIALIEN ZUR VERÄNDERUNG DES VERDAUUNGSORTES; DES WIRKORTES ODER DER STABILITÄTß
WO2009015279A3 (en) Agents and methods for inhibition of airway hyperresponsiveness
Brignardello-Petersen Hyaluronic acid used as an adjunct to coronally advanced flap probably results in an increase in recession reduction and root coverage in patients with single Miller class I gingival recessions
ATE400259T1 (de) Verwendung von colipase-lipase-hemmern bei der herstellung einer pharmazeutischen zusammensetzung zur prävention von adipositas
Farias et al. Cross‐linkers and the Dentin Matrix

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties